Versant Capital Management’s AtriCure ATRC Stock Holding History

Versant Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5K	Buy	89 +43	+93%	+$1.94K	﹤0.01%	2453
2026 Q2	$1.29K	Sell	46 -139	-75%	-$3.91K	﹤0.01%	2616
2026 Q1	$5.28K	Buy	185 +139	+302%	+$4.74K	﹤0.01%	2365
2025 Q4	$1.82K	Hold	46	–	–	﹤0.01%	2459
2025 Q3	$1.62K	Hold	46	–	–	﹤0.01%	2442
2025 Q2	$1.51K	Hold	46	–	–	﹤0.01%	2434
2025 Q1	$1.48K	Hold	46	–	–	﹤0.01%	2311
2024 Q4	$1.41K	Hold	46	–	–	﹤0.01%	2127
2024 Q3	$1.29K	Sell	46 -40	-47%	-$986	﹤0.01%	1681
2024 Q2	$1.96K	Buy	86 +79	+1,129%	+$1.82K	﹤0.01%	1516
2024 Q1	$213	Buy	+7	New	+$234	﹤0.01%	1825

Other funds holding ATRC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nicholas Company Milwaukee, Wisconsin $5.45B AUM 19.89% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Lisanti Capital Growth New York $373M AUM 178.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Versant Capital Management's ATRC Position: Q3 2026 in Review

Versant Capital Management increased its AtriCure (ATRC) stake by 93% in Q3 2026, buying an estimated $1.94K and bringing the position to 89 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

Versant Capital Management first reported a position in ATRC in Q1 2024 and has held it in 11 quarters since. The position peaked at $5.28K in Q1 2026. 115 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

Versant Capital Management held 89 shares of AtriCure worth $5K as of Q3 2026.
Versant Capital Management bought 43 AtriCure shares in Q3 2026, an estimated $1.94K.
AtriCure made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2453 holding.
Versant Capital Management first reported a position in AtriCure in Q1 2024 and has held it in 11 quarters since.
Versant Capital Management's AtriCure position peaked at $5.28K in Q1 2026.
115 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.